iPSC

Stem cells
#High throughput screening #iPSC #Live cell analysis #Organoids #Phenotyping #Stem cells #Webinar

Webinar: Differentiate iPSCs into hepatic lineage cells and organoids

The value of stem cells in laboratory and clinical research has been clearly demonstrated through numerous studies, showcasing their potential as models for a wide range of diseases and therapeutic developments. The inherent flexibility of stem cells allows for the development of various tissue types from a single,… Read More

Webinar date:
Supported by Sartorius
#News

#Axol Bioscience #Cell lines #iPSC #Mergers and acquisitions #Phenocell #Pluripotent stem cells

iPSC technology provider Axol Bioscience acquires Phenocell

Axol Bioscience has fully acquired Phenocell, though financial terms of the agreement were not disclosed. The acquisition extends Axol’s portfolio of iPSC-derived cell models, adding skin and human retinal iPSC-derived cell lines to its existing neuroscience, pain and touch, and cardiovascular products and services. Read More

#Business & Investment #News

#bit bio #EU patent #iPSC #Patent Law #Pluripotent stem cells

bit.bio wins patent defence for opti-ox technology

bit.bio has successfully defended its foundational European patent for opti-ox, a technology the company says enables deterministic forward programming of pluripotent stem cells (PSCs). Following an anonymous opposition filed on 5 January 2023 and a public hearing on 25 September 2024, the European Patent Office’s (EPO)… Read More

#Business & Investment #News

Organoid
#High throughput screening #iPSC #Live cell analysis #Organoids #Phenotyping #Stem cells #Webinar

Register now: Learn streamlined hepatic differentiation techniques

The value of stem cells in laboratory and clinical research has been clearly demonstrated through numerous studies, showcasing their potential as models for a wide range of diseases and therapeutic developments. The inherent flexibility of stem cells allows for the development of various tissue types from a single,… Read More

Webinar date:
Supported by Sartorius
#News

Organoid
#High throughput screening #iPSC #Live cell analysis #Organoids #Phenotyping #Stem cells

From iPSCs to Organoids: Streamlined Hepatic Differentiation Techniques

In this webinar, we describe the process of differentiating human iPSCs into hepatocytes using three distinct media types, each supplemented with specific growth factors and cytokines at key stages of differentiation. This method provides a relatively straightforward approach to producing mature hepatic cells, enabling the generation of human hepatic organoids… Read More

Webinar date:
Supported by Sartorius
#Webinars

#ADME / Tox #Human disease models #In vitro #iPSC #Toxicology

Principles, pitfalls, and progress in modelling human liver toxicity and pharmacology in vitro

In this webinar hosted by DDW and supported by bit.bio, Dr Stephen Ferguson, Investigator, Mechanistic Toxicology, Division of Translational Toxicology (DTT), National Institute of Environmental Health Sciences, explores the complexities of in vitro modelling for human liver toxicity and pharmacology. He discusses the development… Read More

Webinar date:
Supported by bit.bio
#Webinars

#Biology #Cell and gene therapy #Cell therapy #Financing #Harvard Medical School #iPSC

Cell therapy company GC Therapeutics launches with $75m 

GC Therapeutics (GCTx) has launched with $75 million in total capital.  GCTx’s induced pluripotent stem cell (iPSC) programming platform, TFome (Transcription-Factor-ome), was invented and developed by scientists in the lab of Professor George Church at Harvard Medical School and the Wyss Institute.  It integrates synthetic… Read More

#Business & Investment #News

#Assays #Case study #Drug development #Drug discovery #iPSC #Neurology

Case Study: Consistent assays for neurological drug development

A new Case Study is now available to download for free entitled ‘Improving physiological relevance in neurological disease drug development.’ In this case study, hear from Elise Malavasi, PhD, a Principal Scientist at leading contract research organisation Concept Life Sciences. The interview highlights their need to develop… Read More

#News

Case Study: Improving physiological relevance in neurological disease drug development
#Assays #Drug development #Drug discovery #iPSC #Neurology

Improving physiological relevance in neurological disease drug development

In this case study, hear from Elise Malavasi, PhD, a Principal Scientist at leading contract research organisation Concept Life Sciences. The interview highlights their need to develop assays that are amenable to long term use to support their clients with drug development, and how bit.bio’s deterministically programmed ioMicroglia have helped… Read More

#Resources

Human cells
#Cytomos #Immunotherapy #iPSC #Monoclonal antibodies #Single-cell analysis

Cytomos launches new benchtop cell analyser

TechBio Cytomos has launched a new benchtop cell analyser called Celledonia, which uses the company’s AuraCyt platform. Celledonia has been designed to provide cell-specific insights for modalities including monoclonal antibodies (mAbs), T cell immunotherapies, and induced pluripotent stem cells (iPSCs). The new technology could… Read More

#News

CRISPR gene editing
#CRISPR #CRISPR-Cas9 #Gene editing #HPV #Immunotherapy #iPSC #Oncology

Discovery paves the way to ‘off-the-shelf’ cervical cancer therapy

Researchers from Japan have used CRISPR gene editing to enhance the effectiveness of rejuvenated cytotoxic T lymphocytes (rejTs) for targeted immunotherapy. RejTs constitute a promising approach for treating cervical cancer, though rejection by the host’s immune system is a major hurdle. In a recent… Read More

#Cancer Research #Editor's Choice #News

Neuron
#ALS #Human disease models #iPSC #Neurology #Pluripotent stem cells #Stem cells #Whitepaper

Whitepaper: Explore iPSC-derived motor neuron morphology

A new whitepaper is now available from DDW and Sartorius entitled ‘iPSC-Derived Motor Neurons and Microglia From ALS Background Display Disease Phenotype’. Induced pluripotent stem cell (iPSC)-derived cells are a significant resource for disease modelling. They allow the use of cells directly from affected patients… Read More

#News

#ALS #Drug discovery #Human disease models #iPSC #Neurology #Pluripotent stem cells #Stem cells

Using patient-specific cells for disease modelling

Induced pluripotent stem cell (iPSC)-derived cells are a significant resource for disease modelling. They allow the use of cells directly from affected patients and have the potential to guide these cells towards multiple lineages. Download the whitepaper to: Explore iPSC-derived motor neuron morphology Discover how ALS disease phenotype… Read More

#Resources

Cells under a microscope
#bit bio #CAR-T #Cell therapy #Interview #iPSC #Stem cells

Scaling up: The need for human cells to give better access to cell therapies

Reece Armstrong speaks to Kathryn Golden, SVP Technical Operations and Manufacturing, bit.bio, about novel technologies, and methods to manufacture human cells for therapies so more patients can access these treatments. Cell therapies have emerged as transformative and potentially curative treatments across a range of disease… Read More

#Exclusive Content

Researchers in a lab
#Drug development #Gene therapy #iPSC #Preclinical development #Webinar

How iPSC derived cells can support drug and gene therapy development

DDW recently hosted a webinar ‘Discover how iPSC derived cells can be used to support the development of drug and gene therapies’, supported by DefiniGEN. The event outlined how iPSC derived cells can be used to advance the efficiency and efficacy of disease modelling and covered topics including… Read More

#Exclusive Content

#Drug discovery #iPSC #Neurology #Preclinical development #Preclinical investigations

Case Study: How to generate publishable data in just 12 weeks

A new resource is now available to download for free from sponsors Bit Bio: ‘Speeding up neuroscience research: Generating publishable data in 12 weeks‘. In this Case Study you will learn: How Professor Deepak Srivastava’s lab at King’s College London are working to unpick the complex… Read More

#News